← All claims

Diets

mediterranean diet decreases depressive symptoms

In plain terms: Can switching to a Mediterranean diet ease depression symptoms?

Leans support Diets 🔬 Includes disconfirming

Part of: 🥗 mediterranean diet

RefutedContestedStrong support
consensus score 0.53

Well-supported for TREATING depressive symptoms — several RCTs (AMMEND, HELFIMED) and meta-analyses of dietary interventions show a real reduction. The caveat is prevention: the largest prevention trial (MooDFOOD) did not stop depression onset, so the benefit is for existing symptoms rather than preventing new cases.

📅 Last reviewed: 2026-07-15 ⓘ

Evidence ladder

How far up the ladder this claim has climbed. A high consensus on a low rung means "consistent so far," not "proven in people."

Top evidence so far: All trials, pooled (Meta-analysis)

MechanismIn-vitroAnimalObservationalRCTMeta-analysis

How the studies fall

13 support 2 contradict 2 tested null 3 mixed · 20 sources, 15 independent groups · 1 superseded — pooled inside a review, counted once

What the evidence shows

Randomised trials including HELFIMED and AMMEND show Mediterranean-style diets improving depressive symptoms, supported by cross-sectional associations. The counterweight is important: a meta-analysis of five randomised trials in 952 adults with major depressive disorder or elevated symptoms found no significant effect, so this is better evidenced as an adjunct than as a treatment.

The evidence (21)

SourceGradeStanceQualityFinding
Parletta N, Zarnowiecki D, Cho J, Wilson A, Bogomolova S, Villani A, Itsiopoulos C, Niyonsenga T, Blunden S, Meyer B, Segal L, Baune BT, O'Dea K
2019 · Nutr Neurosci
RCT supports moderate HELFIMED RCT: Mediterranean-style diet plus fish oil improved depression scores and mental health versus social-group control.
Jacka FN, O'Neil A, Opie R, Itsiopoulos C, Cotton S, Mohebbi M, Castle D, Dash S, Mihalopoulos C, Chatterton ML, Brazionis L, Dean OM, Hodge AM, Berk M
2017 · BMC Med
RCT supports moderate SMILES RCT: modified MedDiet dietary support vs social support in adults with major depression; significant improvement in MADRS depression scores over 12 weeks (small, unblinded).
↩ SUPERSEDED — pooled in the review above, counted once
Tavakoly R, Moosburner A, Anheyer D, Cramer H
2025 · Nutrients
meta-analysis contradicts low Meta-analysis of 5 RCTs (n = 952) in adults with major depressive disorder or elevated depressive symptoms: no significant effect of Mediterranean-diet intervention on depressive symptom severity short-term vs active (SMD −1.25 [95% CI −5.11 to 2.61]) or passive control (SMD −0.22 [−0.74 to 0.29]), intermediate-term (SMD −0.14 [−0.98 to 0.70]) or long-term (SMD −0.16 [−1.13 to 0.81]). Authors conclude 'The MD appears to have no potential influence on major depressive disorder.' Overall risk of bias 'some concerns' (one trial high risk); GRADE certainty 'very low' for most results, with extremely serious imprecision. Publication bias not assessed (<10 studies).
Depreli A et al
2026 · Healthcare (Basel, Switzerland)
observational supports low Cross-sectional, n=72 child/adolescent crime victims. KIDMED (MedDiet quality index) inversely correlated with KADS depression score (p<0.05); regression: lower KIDMED among strongest predictors of depression severity (model R²=82.2%).
Mela V, Ortiz Samur NS, Vijaya AK, G&#xe1;lvez VJ, Garc&#xed;a-Mart&#xed;n ML, Bandera B, Mart&#xed;nez-Montoro JI, G&#xf3;mez-P&#xe9;rez AM, Moreno-Indias I, Tinahones FJ
2026 · Brain Behav Immun
RCT mixed low Pilot RCT: Mediterranean diet eased depression/anxiety in obesity more than ketogenic diet, but small exploratory sample.
Tirani SA, Grigorian A, Lotfi K, Shahdadian F, Hajhashemy Z, Rouhani P, Saneei P
2025 · BMC psychiatry
observational supports low Iranian cross-sectional, n=527. Highest vs lowest MED-diet tertile: depressive symptoms OR=0.21 (95%CI 0.08-0.48); anxiety OR=0.12 (95%CI 0.02-0.67); distress OR=0.39 (95%CI 0.21-0.72).
Huang Y, Yao K
2026 · European archives of psychiatry and clinical neuroscience
observational supports low NHANES 2005-2018, n=26,289. Higher aMED (Alternative MedDiet) score inversely assoc. w/ PHQ-9 depression, women: aOR=0.55 (95%CI 0.42-0.71); overall dose-response (RCS) across dietary indices including aMED.
Pennisi F, Nucci D, Pinto A, Stacchini L, Veronese N, Maggi S, Signorelli C, Baldo V, Gianfredi V
2026 · Nutrition (Burbank, Los Angeles County, Calif.)
observational supports low UniFoodWaste cross-sectional, Italian university students n=2697. Medi-Lite score inversely assoc. w/ PHQ-9≥10 (aOR=0.91, 95%CI 0.88-0.95,p=.001) and continuous PHQ-9 (β=-0.02, 95%CI -0.03,-0.01,p=.001).
Bizzozero-Peroni B, Mart&#xed;nez-Vizca&#xed;no V, Fern&#xe1;ndez-Rodr&#xed;guez R, Jim&#xe9;nez-L&#xf3;pez E, N&#xfa;&#xf1;ez de Arenas-Arroyo S, Saz-Lara A, D&#xed;az-Go&#xf1;i V, Mesas AE
2025 · Nutr Rev
meta-analysis supports moderate Meta-analysis of RCTs: MedDiet interventions reduced depressive symptoms in adults with depression, though few trials and modest certainty.
Bracone F, Di Castelnuovo A, Costanzo S, Gialluisi A, Ruggiero E, Cerletti C, Donati MB, de Gaetano G, Iacoviello L, Bonaccio M, Moli-sani Study Investigators
2026 · Clinical nutrition (Edinburgh, Scotland)
observational mixed moderate Moli-sani cohort, n=1417, 12.7y follow-up. Combined ↑MDS/↓UPF: PHQ-2 β=-0.42 (95%CI -0.73,-0.12). MDS-alone or UPF-alone changes only weakly associated; MDS change alone not independently significant.
Vreijling SR, Penninx BWJH, Bot M, Watkins E, Owens M, Kohls E, Hegerl U, Roca M, Gili M, Brouwer IA, Visser M, Beekman ATF, Jansen R, Lamers F
2022 · Psychol Med
RCT tested-null high MooDFOOD multi-center RCT in overweight adults with subsyndromal symptoms: dietary intervention did NOT prevent depression onset or reduce symptoms.
Firth J, Marx W, Dash S, Carney R, Teasdale SB, Solmi M, Stubbs B, Schuch FB, Carvalho AF, Jacka F, Sarris J
2019 · Psychosom Med
meta-analysis supports high Meta-analysis of 16 RCTs found dietary interventions significantly reduced depressive symptoms (SMD ~0.28).
Hern&#xe1;ndez-Cacho A, Ni J, Garc&#xed;a-Gavil&#xe1;n JF, Konstanti P, Belzer C, Vioque J, Corella D, Fit&#xf3; M, Vidal J, Torres-Collado L, Coltell O, Babio N, Hernando-Redondo J, Moreno-Indias I, Ruiz-Canela M, Tinahones FJ, Salas-Salvad&#xf3; J
2026 · MedComm
observational supports moderate Elderly Mediterranean cohort, n=644, 1-yr follow-up, 16S sequencing. MEDAS and erMEDAS adherence associated w/ depressive symptoms via gut-microbiota mediation: ACME=-0.066 (p=.006) MEDAS; -0.029 (p=.011) erMEDAS.
Jacka FN, O'Neil A, Itsiopoulos C, Opie R, Cotton S, Mohebbi M, Castle D, Dash S, Mihalopoulos C, Chatterton ML, Brazionis L, Dean OM, Hodge A, Berk M
2018 · BMC Med
observational supports low Author response acknowledging expectation-bias/blinding limitations of SMILES; frames it as a preliminary first step, not definitive.
Abdel Sater RF, Younes RS, Julien SG
2025 · Frontiers in nutrition
observational supports low Lebanon cross-sectional, n=525. MEDAS inversely correlated w/ PHQ-9 (r=-0.126, p=.003); MEDAS scores differed significantly between depressed vs non-depressed groups (7.4±2.4 vs 7.9±2.5, p=.033).
Diez-Hern&#xe1;ndez M, Zer&#xf3;n-Rugerio MF, Parilli-Moser I, Izquierdo-Pulido M
2026 · Nutrients
observational mixed low 12-wk single-arm hypocaloric MedDiet-style pre-post study, n=28 (19F/9M). Depression improved in men only (p=.027); no significant depression change reported in women.
Caama&#xf1;o-Navarrete F, Hern&#xe1;ndez-Mosqueira C, Contreras-Diaz G, Del-Cuerpo I, Jerez-Mayorga D, Herrera-Valenzuela T, Guzm&#xe1;n-Mu&#xf1;oz E, Hernandez-Martinez J, Vald&#xe9;s-Badilla P, N&#xfa;&#xf1;ez-Espinosa C, Delgado-Floody P
2026 · Children (Basel, Switzerland)
observational supports low Cross-sectional, Chilean adolescents n=322. Higher MedDiet adherence (MDA) inversely associated with anxiety (b=-0.23,p=.044), stress (b=-0.25,p=.022), total distress (b=-0.72,p=.022); conclusion states MDA directly linked to lower depressi
Thesing CS, Milaneschi Y, Bot M, Brouwer IA, Owens M, Hegerl U, Gili M, Roca M, Kohls E, Watkins E, Visser M, Penninx BWJH
2020 · Depress Anxiety
observational tested-null moderate MooDFOOD prevention trial: supplement-induced increases in omega-3 were not associated with reduced depressive symptoms.
Sharifi MH, Poursadeghfard M, Afshari M, Alizadeh Z, Vatanpour M, Soltani M, Molavi Vardanjani H, Jaladat AM, Nimrouzi M
2025 · Iran J Med Sci
RCT contradicts low Three-arm RCT, 90 adults with multiple sclerosis, 2 months: modified Mediterranean vs Traditional Persian vs control advice. Clean null for Mediterranean on Beck depression: crude mean difference vs control 0.6 (95% CI -2.31 to 3.51), p=0.68; adjusted 1.50 (-1.12 to 4.13), p=0.22; post-intervention means MED 9.26 vs control 9.56. Authors: MED 'could reduce fatigue scores ... while having no effect on the depression score'. The depression reduction was in the Traditional Persian arm (-2.89, -5.59 to -0.19). MS population.
Bayes J, Schloss J, Sibbritt D
2022 · Am J Clin Nutr
RCT supports moderate AMMEND RCT: 12-week Mediterranean diet significantly reduced depression symptoms versus befriending control in young men.
Turner M, Ashtree DN, Lane MM, Anastasiou K, Hadjikakou M, Dawson SL, Lawrence M, Jennings L, Geyik O, Jacka FN, Versace VL, Chatterton ML, Absetz P, Bryan M, Brayner B, Mahoney S, Saunders D, John T, Young LM, O'Neil A
2025 · Br J Nutr
RCT supports low CALM/lifestyle RCT: Mediterranean-style dietary intervention reduced depressive symptoms in adults.

Disagree, or know a study we missed?

We grade by evidence, not opinions. The way to weigh in is to point us to a study we haven't cited (check the evidence table above first), or to flag a problem with one we have. Every submission is reviewed; if it holds up, the grade updates and shows in Science Changes Its Mind.

📚 Suggest a study ⚑ Flag / request reclassification

Opens a short form. You'll sign in with Google so submissions are tied to a real account — we don't display your identity, and we only accept a link we can verify (PubMed, DOI, ClinicalTrials.gov).

Educational only, not medical advice. Grades and scores reflect published evidence weighted by study design and quality; see the methodology.